#1 Clinical Trials Search in Europe

Mitomycin

Mitomycin is a powerful drug being studied in clinical trials for its potential to treat a variety of medical conditions. This article explores how Mitomycin is being used in different types of clinical trials, including cancer treatment, eye surgeries, and urological procedures. We’ll look at the drug’s effectiveness, safety, and potential benefits for patients across multiple medical specialties.

Table of Contents

What is Mitomycin?

Mitomycin, also known as Mitomycin C, is a powerful medication used in various medical treatments. It belongs to a class of drugs called antineoplastic antibiotics, which means it can fight cancer cells and prevent their growth. Mitomycin is derived from the Streptomyces caespitosus bacterium and has been used in medicine for several decades[1].

This drug is known by several other names, including:

  • Ametycine
  • MITO or MITO-C
  • Mitocin or Mitocin-C
  • Mitolem
  • Mitosol
  • Mitozytrex
  • Mutamycin or Mutamycine

Uses of Mitomycin

Mitomycin is used to treat various conditions, including:

  • Cancer: It is used in the treatment of several types of cancer, particularly colorectal cancer and anal canal cancer[2][3].
  • Glaucoma: Mitomycin is used during glaucoma surgery to prevent scarring and improve the success rate of the procedure[4].
  • Bladder Cancer: It’s used in the treatment of superficial bladder cancer[5].
  • Urethral Stricture: Mitomycin is being studied for its potential in treating recurrent urethral strictures[6].

How Mitomycin Works

Mitomycin works by interfering with the DNA of cells, which prevents them from dividing and growing. This action is particularly effective against cancer cells, which tend to divide rapidly. In addition to its anti-cancer properties, Mitomycin also has the following effects:

  • It inhibits the growth of fibroblasts, which are cells involved in forming scar tissue.
  • It reduces the release of matrix proteins, which are important in tissue healing and scar formation.
  • It has anti-proliferative (stopping cell growth) and anti-scarring properties[6].

Administration Methods

Mitomycin can be administered in several ways, depending on the condition being treated:

  • Intravenous (IV) injection: The drug is injected directly into a vein, often used in cancer treatment[2].
  • Topical application: In eye surgeries, Mitomycin may be applied directly to the surgical site using a sponge[7].
  • Intravesical administration: For bladder cancer, the drug is introduced directly into the bladder through a catheter[5].
  • Intralesional injection: In some cases, Mitomycin may be injected directly into the affected tissue, such as in urethral stricture treatment[6].

Mitomycin in Cancer Treatment

Mitomycin plays a significant role in cancer treatment, particularly for colorectal and anal canal cancers. It is often used in combination with other treatments:

  • Chemoradiotherapy: Mitomycin is frequently combined with radiation therapy and other chemotherapy drugs like capecitabine or 5-fluorouracil. This combination has shown effectiveness in treating anal canal cancer[2][8].
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC): In some cases of advanced colorectal cancer, Mitomycin is used in a procedure called HIPEC, where the drug is heated and circulated in the abdominal cavity during surgery[3].

Mitomycin in Eye Surgery

Mitomycin is widely used in ophthalmology, particularly in glaucoma surgery. Its application in this field includes:

  • Trabeculectomy: This is a type of glaucoma surgery where Mitomycin is applied to prevent scarring and improve the success rate of the procedure[4].
  • Ahmed Glaucoma Valve Implantation: Research is being conducted to evaluate the effectiveness of Mitomycin in improving outcomes of this procedure[9].

Mitomycin in Urological Procedures

In urology, Mitomycin is used in several ways:

  • Bladder Cancer Treatment: It’s administered directly into the bladder (intravesical therapy) to treat superficial bladder cancer[5].
  • Urethral Stricture Treatment: Research is ongoing to evaluate the effectiveness of injecting Mitomycin into the urethra after a procedure called visual internal urethrotomy to prevent the recurrence of urethral strictures[6].

Side Effects and Precautions

Like all medications, Mitomycin can cause side effects. These can vary depending on how the drug is administered and what it’s being used to treat. Some potential side effects include:

  • Nausea and vomiting
  • Decreased blood cell counts, which can increase the risk of infection or bleeding
  • Fatigue
  • Skin reactions at the injection site
  • In eye surgeries, it may cause changes in vision or eye discomfort

It’s important to discuss potential side effects with your healthcare provider before starting treatment with Mitomycin.

Ongoing Research

Researchers continue to study Mitomycin to find new uses and improve its effectiveness. Some areas of ongoing research include:

  • Comparing different methods of applying Mitomycin in eye surgeries to determine the most effective approach[7].
  • Evaluating the use of Mitomycin in combination with other treatments for various types of cancer[10].
  • Investigating the potential of Mitomycin in treating recurrent urethral strictures[6].

As research continues, our understanding of Mitomycin and its potential uses may expand, potentially leading to new treatments and improved outcomes for patients.

Condition Trial Type Mitomycin Use Key Outcomes Measured
Anal Cancer Phase III Randomized Combined with capecitabine and radiotherapy 3-year disease-free survival, complete response rate
Glaucoma Randomized Controlled Intraoperative application during trabeculectomy Intraocular pressure reduction, bleb morphology
Urethral Stricture Randomized Controlled Intralesional injection after urethrotomy Stricture recurrence rate, urinary flow
Pterygium Randomized Controlled Topical application after surgery Pterygium recurrence rate, complications
Bladder Cancer Randomized Controlled Neoadjuvant intravesical instillation 2-year recurrence rate, tumor response rate
Upper Urinary Tract Cancer Single Arm Phase II Intraoperative intravesical instillation Bladder tumor recurrence rate, time to recurrence

FAQ

  • What is Mitomycin and how does it work? Mitomycin is an antineoplastic antibiotic that inhibits DNA synthesis and cell division. It works by cross-linking DNA strands, which prevents cells from multiplying. This makes it useful for treating cancer and preventing excessive tissue growth after certain surgeries.
  • In which medical conditions is Mitomycin being studied? Mitomycin is being studied in clinical trials for various conditions, including anal cancer, glaucoma, urethral strictures, pterygium (eye growth), bladder cancer, and upper urinary tract urothelial carcinoma.
  • How is Mitomycin administered in these clinical trials? The administration of Mitomycin varies depending on the condition being treated. It may be given as an intravenous injection, applied topically to the eye, injected into the bladder, or used as a subconjunctival injection during eye surgery.
  • What are some potential benefits of using Mitomycin in clinical trials? Potential benefits include improved cancer treatment outcomes, reduced recurrence rates after surgeries, lower intraocular pressure in glaucoma patients, and decreased scarring in various procedures. However, the exact benefits depend on the specific condition and trial design.
  • Are there any side effects or risks associated with Mitomycin use in clinical trials? Like all medications, Mitomycin can have side effects. These may include eye irritation when used in ophthalmic procedures, bladder irritation when used for bladder cancer, and potential systemic effects when given intravenously. The specific risks and side effects are carefully monitored in each clinical trial.

Ongoing Clinical Trials on Mitomycin

  • A study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Italy The Netherlands +1

  • Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Hungary Latvia Poland Romania Spain

  • Study on the Effectiveness and Safety of Mitomycin C with Electric Current for Treating Non-Muscle Invasive Bladder Cancer in Patients, Compared to Standard Immunotherapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Iceland Norway Sweden

  • Study of Ezabenlimab and Drug Combination for Stage III Anal Cancer Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study comparing BCG and combination of BCG with electromotive mitomycin-C treatment in patients with high-risk non-muscle-invasive bladder cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study on Bladder Cancer: Testing Cisplatin and Drug Combination for Patients with Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effectiveness of Heated Chemotherapy with Mitomycin-C for Patients with Colon Cancer Spread to the Peritoneum After Surgery

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +4

  • Study of Mitomycin-C with Electromotive Drug Administration before Surgery in Patients with Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Trabeculectomy: A surgical procedure used to treat glaucoma by creating a new drainage channel to reduce intraocular pressure.
  • Intraocular pressure (IOP): The fluid pressure inside the eye, which is important in the diagnosis and management of glaucoma.
  • Visual Internal Urethrotomy (VIU): A surgical procedure used to treat urethral strictures by making an incision in the narrowed area of the urethra.
  • Pterygium: A growth of tissue on the surface of the eye that can extend from the white of the eye onto the cornea.
  • Urothelial carcinoma: A type of cancer that typically occurs in the urinary system, including the bladder and upper urinary tract.
  • Nephroureterectomy: A surgical procedure to remove the kidney and the entire ureter, often used to treat upper urinary tract cancers.
  • Chemoradiotherapy: A treatment that combines chemotherapy and radiation therapy, often used in cancer treatment.
  • Squamous cell carcinoma: A type of skin cancer that develops in the squamous cells, which make up the middle and outer layers of the skin.
  • Intensity-modulated radiotherapy (IMRT): An advanced form of radiation therapy that uses computer-controlled linear accelerators to deliver precise radiation doses to tumors or specific areas within tumors.

References

  1. https://clinicaltrials.gov/study/NCT01017640
  2. https://clinicaltrials.gov/study/NCT01843452
  3. https://clinicaltrials.gov/study/NCT02614534
  4. https://clinicaltrials.gov/study/NCT00538590
  5. https://clinicaltrials.gov/study/NCT01442519
  6. https://clinicaltrials.gov/study/NCT06232005
  7. https://clinicaltrials.gov/study/NCT03875911
  8. https://clinicaltrials.gov/study/NCT01941966
  9. https://clinicaltrials.gov/study/NCT06680245
  10. https://clinicaltrials.gov/study/NCT02526953